Dr.Reddy's in Talks to Buy UCB India Business for $135 mn - Source

Published: 10th March 2015 03:35 PM  |   Last Updated: 10th March 2015 03:35 PM   |  A+A-

MUMBAI: Indian drugmaker Dr.Reddy's Laboratories Ltd is in talks to acquire the Indian operations of Belgian pharmaceutical company UCB SA for about $135 million, said a person with direct knowledge of the matter.

The acquisition would be funded by Dr.Reddy's existing cash balance, the person said. He declined to be identified because he was not authorised to talk to media.

UCB was not immediately available for comment. A Dr.Reddy's spokesman declined to comment.

Dr.Reddy's had cash and market investments worth $456 million, according to a company presentation in February.

UCB's Indian unit employs more than 450 employees and its product portfolio in India includes drugs used for the treatment of allergies, epilepsy and respiratory disorders, according to its website.

The talks come as large Indian drugmakers such as Dr.Reddy's and Glenmark Pharmaceuticals Ltd seek to bolster their presence in the domestic market, as some key export markets such as Russia suffer an economic slowdown.


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp